How the minefield that is socia media could actually prove beneficial for the world of pharma.
Blog
Chairman, GDS International
Latest News
CureFAKtor Pharmaceuticals Receives Orphan Drug Designation
CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the...
read moreComments
Pharma to See Big Growth in East in 2011
According to investment international, 2011 will be a successful year for the pharmaceutical...
read moreComments
Neovacs: Crohn's Disease Immunotherapy Trial Success
Neovacs, a biotechnology company focused on active immunotherapy for autoimmune and inflammatory...
read moreComments
Aspirin Reduces Cancer Risk by 21%
British researchers revealed in an article published in The Lancet that a daily dose in the range...
read moreComments
Ian Read to Replace Jeffrey Kindler as Pfizer CEO
Pfizer, the world's largest pharmaceutical company has announced that CEO Jeffrey Kindler has...
read moreComments
Survey: FDA and Industry Relationship Complicated
PricewaterhouseCoopers (PwC) most recent survey ‘Improving America's Health V- A survey of the...
read moreComments
Johnson & Johnson Recalls Benadryl Allergy Tablets
Johnson & Johnson has recalled four million packages of Children's Benadryl allergy tablets and...
read moreComments
Resverlogix Announces Top ASSERT Results
Resverlogix Corp. (Resverlogix) (TSX:RVX) announces its top line results of the ASSERT Phase 2...
read moreComments
Warfarin Shown to be Less Effective Than Xarelto in Study
Johnson & Johnson's Warfarin, the gold standard anti-clotting drug has been shown to be less...
read moreComments
NGP Europe Summit: Drug Discovery
5th - 7th April 2011
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.